Eltagonde, Rowena C.
HRN: 10-89-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2024
CEFTRIAXONE 1G (VIAL)
11/09/2024
11/16/2024
IV
2g
OD
Avulsed Woubd
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes